Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Werf, M. J.
Right arrow Articles by van Berkel, W. J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Werf, M. J.
Right arrow Articles by van Berkel, W. J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 37, 26296-26304, September 10, 1999


Stereoselective Carveol Dehydrogenase from Rhodococcus erythropolis DCL14
A NOVEL NICOTINOPROTEIN BELONGING TO THE SHORT CHAIN DEHYDROGENASE/REDUCTASE SUPERFAMILY*

Mariët J. van der WerfDagger §, Cornelly van der VenDagger , Fabien BarbiratoDagger , Michel H. M. Eppink, Jan A. M. de BontDagger , and Willem J. H. van Berkel

From the Dagger  Division of Industrial Microbiology, Department of Food Technology and Nutritional Sciences, Wageningen University, Bomenweg 2, 6703 HD Wageningen, The Netherlands and the  Laboratory of Biochemistry, Department of Biomolecular Sciences, Wageningen University, Dreijenlaan 3, 6703 HA Wageningen, The Netherlands

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A novel nicotinoprotein, catalyzing the dichlorophenolindophenol-dependent oxidation of carveol to carvone, was purified to homogeneity from Rhodococcus erythropolis DCL14. The enzyme is specifically induced after growth on limonene and carveol. Dichlorophenolindophenol-dependent carveol dehydrogenase (CDH) is a homotetramer of 120 kDa with each subunit containing a tightly bound NAD(H) molecule. The enzyme is optimally active at pH 5.5 and 50 °C and displays a broad substrate specificity with a preference for substituted cyclohexanols. When incubated with a diastereomeric mixture of (4R)- or (4S)-carveol, CDH stereoselectively catalyzes the conversion of the (6S)-carveol stereoisomers only. Kinetic studies with pure stereoisomers showed that this is due to large differences in Vmax/Km values and simultaneous product inhibition by (R)- or (S)-carvone. The R. erythropolis CDH gene (limC) was identified in an operon encoding the enzymes involved in limonene degradation. The CDH nucleotide sequence revealed an open reading frame of 831 base pairs encoding a 277-amino acid protein with a deduced mass of 29,531 Da. The CDH primary structure shares 10-30% sequence identity with members of the short chain dehydrogenase/reductase superfamily. Structure homology modeling with trihydroxynaphthalene reductase from Magnaporthe grisea suggests that CDH from R. erythropolis DCL14 is an alpha /beta one-domain protein with an extra loop insertion involved in NAD binding and a flexible C-terminal part involved in monoterpene binding.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Terpenes are the largest class of secondary plant metabolites (1). They are generally regarded as derivatives of isoprene and are classified based on the number of isoprene units linked. Monoterpenes are branched chain C-10 hydrocarbons formed from two isoprene units. They are widely distributed in nature, and over 400 different naturally occurring monoterpenes have been identified (2). Volatile monoterpene emission from trees is estimated at 127 × 1014 g carbon/year (3).

Limonene (4-isopropenyl-1-methylcyclohexene), a monocyclic monoterpene, is the most widespread terpene in the world and is formed by over 300 plants (4). (4R)-(+)-Limonene is the most widespread form. (4R)-Limonene is the major constituent of citrus peel essential oils, where it is usually found in concentrations between 90 and 96% (5). However, several plants form a mixture of both enantiomers of limonene, whereas others produce only the (4S)-enantiomer (4).

Several pathways for the microbial degradation of limonene have been postulated so far (6-10), but most of these pathways have not been substantiated by biochemical studies. The best studied microbial degradation pathway for limonene involves the hydroxylation at the C7-methyl group resulting in the formation of perillyl alcohol (6, 7). Two enzymes of this pathway, perillyl alcohol dehydrogenase and perillyl aldehyde dehydrogenase, have been partially purified (11, 12). Also an enzyme from one of the other limonene transformation pathways, alpha -terpineol dehydratase, was partially purified from two different Pseudomonas species (8, 13).

We recently isolated Rhodococcus erythropolis DCL14, a strain able to grow on limonene as sole carbon and energy source that contains a novel degradation pathway for limonene (14). Cells grown on limonene and carveol were found to contain a DCPIP1-dependent carveol dehydrogenase (CDH) that converts carveol into carvone (Fig. 1). We here report on the purification, characterization, gene cloning, sequence determination, and structure homology modeling of this novel enzyme.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   Reaction catalyzed by DCPIP-dependent CDH from R. erythropolis DCL 14. Numbers in carveol refer to the carbon atom numbering.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Organism and Culture Conditions

R. erythropolis DCL14 was isolated with (4R)-dihydrocarveol as the carbon and energy source as described previously (15). The strain was subcultured every month and grown at 30 °C on a yeast extract-glucose agar plates for 2 days, after which the plates were stored at room temperature. Cultures were grown in 5-liter Erlenmeyer flasks containing 1 liter of mineral salts medium (16) with 0.01% (v/v) carbon source and fitted with rubber stoppers. The flasks were incubated at 30 °C on a horizontal shaker oscillating at 1 Hz with an amplitude of 10 cm. After growth was observed, the concentration of the toxic substrates was increased with daily steps of 0.01% (v/v) until a total of 0.1% (v/v) carbon source had been added.

Cells for enzyme purification were grown fed-batch on limonene in a fermentor as described previously (15). Cells were collected by centrifugation (4 °C, 10 min at 16,000 × g) and washed with 50 mM potassium phosphate buffer, pH 7.0. The pellet was resuspended in 7 ml of this buffer containing 0.1% Tween 80 and stored at -20 °C.

Chemicals

(4R)-Carveol (mixture of two diastereomers), (-)-(R)- and (+)-(S)-carvone were from Acros and DCPIP was from Merck. SDS was purchased from BDH. NAD+ (100%), NADP+ (98%), NADH (98%), and NADPH (98%) were obtained from Roche Molecular Biochemicals. DEAE-Sepharose CL-6B, Octyl Sepharose, Sephacryl S300, Superdex 200 HR 10/30, and Resource-Q were obtained from Amersham Pharmacia Biotech. Hydroxyapatite and Bio-Gel P6DG were from Bio-Rad. (4S)-Carveol (mixture of two diastereomers) was prepared by reducing (S)-carvone with lithium aluminum hydride. (+)-(4S, 6S)-cis- (97.8%), (+)-(4S, 6R)-trans- (94.6%), (-)-(4R, 6R)-cis- (96.8%), and (-)-(4R, 6S)-trans-carveol (99.2%) were obtained after preparative GC separation. 30 µl of a 10% (4R)- or (4S)-carveol solution in acetone was injected on a packed column (2.0 m × 4 mm) filled with 8.6 g of Chromsorb 100-120 containing 9.8% Carbowax. GC was performed on a Varian model 3700 GC equipped with an thermo conductor detector. The detector and filament temperatures were 230 and 260 °C, respectively. The injector and oven temperatures were 200 and 120 °C, respectively, and the flow of the carrier gas (H2) was 30 ml/min. The stereoisomers were identified by their MS spectra and by comparing the retention times after chiral and nonchiral GC with that of standards: (4S, 6S)-carveol; tR = 13.66 min (alpha -DEX 120, 120 °C), tR = 8.04 min (HP-5MS, temperature program), MS: m/z 152 [M+] (1), 137 (10), 134 (49), 123 (11), 119 (29), 109 (65), 91 (30), 84 (100), 69 (46), 55 (58), 41 (62). (4S, 6R)-carveol; tR = 12.43 min (alpha -DEX 120, 120 °C), tR = 7.79 min (HP-5MS, temperature program), MS: m/z 152 [M+] (6), 137 (10), 134 (2), 123 (7), 119 (13), 109 (100), 91 (25), 84 (59), 69 (28), 55 (36), 41 (45). (4R, 6R)-carveol; tR = 13.45 min (alpha -DEX 120, 120 °C), tR = 8.04 min (HP-5MS, temperature program), MS spectrum: same as that of (4S, 6S)-carveol. (4R, 6S)-carveol; tR = 12.29 min (alpha -DEX 120, 120 °C), tR = 8.04 min (HP-5MS, temperature program), MS spectrum: same as that of (4S, 6R)-carveol. All other chemicals were of the highest purity commercially available.

Preparation of Cell Extract

Aliquots of the frozen cell suspension (7 ml) were thawed and disrupted by sonication (20 min, 30% duty cycle, output control 2.3) with a Branson sonifier 250. Cell debris was removed by centrifugation at 20,000 × g for 20 min (4 °C). The supernatant was used as the cell extract.

Carveol Dehydrogenase Assay

NAD(P)+-dependent CDH activity was determined spectrophotometrically by monitoring the formation of NAD(P)H at 340 nm (epsilon 340 = 6.22 mM-1 cm-1). Activity was measured at 30 °C in an incubation (1 ml) containing 100 µl of cell extract, 50 mM Tris/HCl buffer, pH 9.0, 1 mM NAD(P)+, and 1 mM carveol. The reaction was started by the addition of substrate. Specific activities were calculated from the linear part of the reaction and were corrected for endogenous activity. DCPIP-dependent CDH activity was determined spectrophotometrically by monitoring the decrease in absorbance at 600 nm due to the reduction of DCPIP. Activity was measured at 30 °C in an incubation (1 ml) containing 25 µl of enzyme solution, 50 mM citrate buffer, pH 6.0, 0.075 mM DCPIP, and 1 mM carveol. The molar absorption coefficient for DCPIP at 600 nm and pH 6.0 was epsilon 600 = 16.9 mM-1 cm-1. One unit of CDH activity was defined as the amount of enzyme that converted 1 µmol of DCPIP/min under assay conditions. For the determination of the pH optimum of enzyme catalysis, the pH dependence of the molar absorption coefficient of DCPIP was corrected for (17). Steady state kinetic parameters were determined from incubations (1 ml; 30.0 °C) containing 6.7 µg of CDH, 50 mM citrate buffer, pH 5.5, 0.10 mM DCPIP, and substrate at concentrations ranging between 0.015 and 3.5 mM enantiopure carveol. For the determination of product inhibition constants (Ki), 0.2 mM enantiopure carvone was added to the assay. The molar absorption coefficient for DCPIP at 600 nm and pH 5.5 was epsilon 600 = 12.9 mM-1 cm-1. Apparent Km, Ki, and Vmax values were calculated from Lineweaver-Burk plots as described previously (18). The substrate specificity of CDH was determined by replacing carveol in the standard activity assay with 1 mM of the other substrates. DCPIP was reduced chemically by adding an equimolar amount of ascorbate (17).

The stereoselectivity of CDH was determined by monitoring carveol conversion by chiral GC. Different vials (15 ml) containing the reaction mixture were started at the same time. The reaction mixtures (2 ml) consisted of CDH, 50 mM citrate buffer, pH 6.0, 3 mM DCPIP, and 2 mM carveol. The vials were fitted with Teflon Mininert valves (Supelco Inc.) preventing the evaporation of carveol. The vials were placed in a shaking water bath (30 °C), and periodically a vial was removed from the water bath, and the reaction was terminated by the addition of 1 ml of ethyl acetate. The vials were vigorously shaken to accomplish quantitative extraction of the terpenes. The ethyl acetate layer was pipetted in a microcentrifuge tube and centrifuged (3 min, 13.000 rpm) to achieve optimal separation of the two layers. Subsequently 1 µl of the ethyl acetate layer was analyzed by GC.

Enzyme Purification

All purification steps were performed at 4 °C. Buffers contained 10% glycerol and 0.1% Tween 80, and the pH was 7.0. If necessary, pooled fractions were concentrated by ultrafiltration with an Amicon ultrafiltration unit using a YM-10 membrane.

Hydrophobic Interaction Chromatography-- Cell extract (15 ml) was applied onto an Octyl Sepharose column (2.5 × 31 cm) equilibrated with 25 mM potassium phosphate buffer containing 1 M NaCl and eluted with the same buffer (flow rate, 0.75 ml/min; collected fraction volume, 7.5 ml). Fractions containing DCPIP-dependent CDH activity were pooled and adjusted to 80% ammonium sulfate saturation. After 15 min at 0 °C, the precipitate was collected by centrifugation (15 min at 27,000 × g). The pellet was resuspended in 5 ml of 15 mM potassium phosphate buffer.

Gel Filtration-- The solubilized precipitate was applied onto a Sephacryl S300 column (2.5 × 98 cm) equilibrated with 15 mM phosphate buffer and eluted with the same buffer (flow rate, 0.75 ml/min; collected fraction volume, 7.5 ml). Fractions containing CDH activity were pooled.

Hydroxyapatite Chromatography-- The pooled fractions from the gel filtration step were applied to a hydroxyapatite column (5 × 6 cm) equilibrated with 15 mM potassium phosphate buffer and eluted with the same buffer (flow rate, 0.5 ml/min; collected fraction volume, 5 ml). The fractions containing CDH activity were pooled.

Anion Exchange Chromatography-- The pooled fractions from the hydroxyapatite chromatography step were applied onto a DEAE Sepharose CL-6B column (2.5 × 31 cm) equilibrated with 25 mM potassium phosphate buffer. The column was washed with 200 ml of the same buffer (flow rate, 0.75 ml/min; collected fraction volume, 7.5 ml), and subsequently the enzyme was eluted with a linear gradient of 0-1 M NaCl in the same buffer (total volume, 1 liter). CDH eluted at a concentration of 300 mM NaCl. Active fractions were pooled, concentrated by ultrafiltration, and stored at 4 °C.

Electrophoresis and Molecular Mass Determinations

The relative subunit molecular mass of CDH was determined by SDS-polyacrylamide gel electrophoresis. A 12.5% (w/v) slab gel was prepared by the method of Laemmli (19). The Amersham Pharmacia Biotech low molecular mass calibration kit containing phosphorylase b (94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa), and alpha -lactalbumin (14.4 kDa) was used as a reference. Proteins were stained with Coomassie Brilliant Blue G. The relative molecular mass of native CDH was determined by gel filtration on Superdex 200. The column was calibrated with blue dextran 2000, ferritine (440 kDa), catalase (232 kDa), aldolase (158 kDa), p-hydroxybenzoate hydroxylase (88 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), and chymotrypsinogen A (25 kDa).

Identification of Prosthetic Group of CDH

The prosthetic group of CDH was extracted by urea unfolding, essentially as described by Arfman et al. (20). Urea (final concentration, 6 M) was added to 1.85 mg of purified CDH in 1 ml of 25 mM Hepes/NaOH, pH 7.5, containing 1 mM dithiothreitol. After standing for 10 min at 50 °C, the enzyme sample (1.4 ml) was eluted over a Bio-Gel P6DG column (1 × 10 cm), equilibrated with 10 mM Tris/HCl, pH 8.0, containing 6 M urea (buffer A). Fractions of 1 ml were collected and tested for their spectral properties. Samples (200-500 µl) of the liberated prosthetic group were further analyzed on a Resource-Q anion exchange column (30 × 6.4 mm), equilibrated with buffer A at a flow rate of 1 ml min-1. Samples of urea-treated NAD, NADH, NADP, and NADPH (10 nmol of each) served as standards. After sample application, the column was washed with 5 ml of buffer A. Bound nucleotides were then eluted with a 0-0.9 M KCl gradient in 15 ml of buffer A.

Analytical Methods

Protein was determined by the method of Bradford (22) with bovine serum albumin as the standard. The N-terminal amino acid sequence of purified CDH was determined by Edman degradation at the Protein Sequencing Facility Leiden, Department of Medical Biochemistry, Sylvius Laboratory, Leiden, The Netherlands. The metal composition of CDH (16 µM subunit) was determined by inductively coupled plasma-MS using a Perkin-Elmer Elan 6000.

Carveol and carvone were analyzed by chiral GC on fused silica cyclodextrin alpha -DEX 120 capillary column (30 m × 0.25 mm, 0.25-µm film coating; Supelco, Zwijndrecht, the Netherlands). GC was performed on a Chrompack CP9000 GC equipped with an FID detector using N2 (1 ml min-1) as the carrier gas. The detector and injector temperatures were 250 and 200 °C, respectively, and the split ratio was 1:50. The isomers of carveol and carvone were separated at oven temperatures of 120 and 80 °C, respectively. The stereoisomers of carveol and carvone were assigned by comparing the retention times after chiral and nonchiral GC, and their MS spectra were compared with that of standards.

GC-MS analysis was carried out on a HP5970B quadrupole MS coupled to an Hewlett Packard HP6890 GC equipped with a fused silica capillary column (HP-5MS, 30 m × 0.25 mm; film thickness, 0.25 µm). Carrier gas and flow was helium at 1.0 ml min-1. Injector temperature was 220 °C; the temperature program was 70-175 °C at 7 °C min-1. The injection volume was 1 µl (split ratio, 1:50). Electron-impact MS was obtained at 70 eV.

Absorption spectra were recorded at 25 °C on a Hewlett Packard HP 8453 diode array spectrophotometer. Fluorescence spectra were recorded at 20 °C with a SLM-Aminco SPF500C spectrofluorimeter. Measurements were performed in a quartz cuvette (10-mm path length) in a total volume of 1 ml. Fluorescence emission spectra were recorded between 360 and 560 nm (bandwidth, 4 nm) with the excitation wavelength fixed at 280, 295, or 340 nm (bandwidth, 4 nm). Fluorescence excitation spectra were scanned between 240 and 440 nm (bandwidth, 4 nm) at a fixed emission wavelength of 450 nm (bandwidth, 4 nm). All fluorescence spectra were corrected against the appropriate reference solution.

Cloning and Sequencing of the CDH Gene (limC)

The limA gene coding for limonene-1,2-epoxide hydrolase, an enzyme involved in limonene degradation in R. erythropolis DCL14, was cloned using a combination of polymerase chain reaction and colony filter hybridization (21). Using the N-terminal amino acid sequence of the purified enzyme (15), two degenerated primers were designed at the beginning and the end of the 50-amino acid-long stretch. These primers were used to synthesize a homologous probe with which the complete limA gene and the flanking regions were isolated from a cosmid library of R. erythropolis DCL14 (21). The nucleotide sequences of the flanking regions of limA, containing the limC gene, were determined by a combination of subcloning and primer walking. The nucleotide sequences of double stranded inserts in pGEM-T were determined by the DyeDeoxy Terminator Cycle Sequencing kit using AmliTaq FC DNA polymerase (Perkin-Elmer).

Sequence Alignment

For sequence alignment studies a PSI-BLAST (23) search was performed at the National Center for Biotechnology Information for related sequences with known structure. A multiple sequence alignment was performed by superimposing the structures of the selected sequences with the program TOP (24), followed by the addition of the CDH gene to the alignment profile with MACAW (25), and manual optimization.

Structure Homology Modeling

Model building of CDH was performed with MODELLER4 (26) using the CHARMM forcefield (27). The stereochemical quality of the homology model was verified by PROCHECK (28), and the protein folding was assessed with PROFILE (29) and PROSAII (30), which evaluate the compatibility of each residue to its environment independently. After this initial verification, bad regions of the model were optimized with the simulated annealing procedure (molecular dynamics) of the XPLOR package (31), thereby fixing the other parts of the protein. A simulated annealing calculation was performed for 1000 steps at 900 K, with each step taking 0.5 femtosecond. Before and after molecular dynamics the model was energy minimized with the conjugate gradient algorithm of XPLOR (31); the minimization converged after 2000 cycles (gradient, 0.1 kcal/mol). Again, the model was checked and verified. NADH docking was performed with the program O (32), based on highly similar positions of NAD(P)H in SDR structures. NADH forcefield constants for energy minimization were derived from CHARMM. Finally, the model was verified after several rounds of energy minimization.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Induction of CDH Activities in R. erythropolis-- R. erythropolis DCL14 is able to grow on a variety of monoterpenes. During growth on these substrates, several CDH activities are induced (Table I). Both NAD+- and DCPIP-dependent CDH activities were present in cell extracts of R. erythropolis DCL14 grown on (4S)-carveol. Separation by anion exchange chromatography revealed at least four different CDH activities: an NADP+-dependent CDH, an NAD+-dependent CDH with a high activity with (4S)-carveol, an NAD+-dependent CDH with a high activity with (4R)-carveol, and a DCPIP-dependent CDH (results not shown). Only the latter activity was markedly induced after growth on limonene and carveol (Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
(4S)- and (4R)-CDH activities in cell extracts of R. erythropolis DCL14 grown on various carbon sources
Activities are in nmol min-1 mg-1.

Purification of DCPIP-dependent CDH-- During our initial efforts to purify the inducible CDH, the enzyme appeared to be rather unstable, especially at high ionic strength. A mixture of 0.1% (v/v) Tween 80 and 10% (v/v) glycerol stabilized CDH. The purification scheme for CDH is presented in Table II. The enzyme was purified 13-fold with an overall yield of 50%. The ratio of the activity of CDH with (4S)- and (4R)-carveol remained constant during purification. SDS-polyacrylamide gel electrophoresis of the purified enzyme revealed one distinct band, corresponding to a protein with a subunit mass of about 40 kDa (Fig. 2). Analytical gel filtration revealed one symmetric protein peak corresponding to a relative molecular mass of about 120 kDa. Together with the sequence data (see below), this suggests that the native enzyme is a homotetramer. Inductively coupled plasma MS analysis revealed no metal ions as cofactors (<5% mol metal/mol enzyme).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Purification of DCPIP-dependent CDH from (4R)-limonene grown cells of R. erythropolis DCL14
Activity was measured with (4S)-carveol as the substrate.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   SDS-polyacrylamide gel electrophoresis of CDH from R. erythropolis DCL14. Lane 1, 20 µg CDH; lane 2, molecular mass markers.

Spectral Properties-- The absorption spectrum of CDH displayed a typical maximum at 275 nm and a broad band of relatively low intensity around 330 nm (Fig. 3A). Addition of dithionite, carveol, or carvone did not affect the absorption spectrum. Upon excitation at 340 nm, the holoenzyme exhibited a fluorescence emission maximum near 440 nm (Fig. 3B), whereas upon excitation at 280 nm, the native enzyme showed fluorescence emission maxima at 340 and 440 nm (Fig. 4A). This indicates that CDH contains protein-bound NAD(P)H.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Spectral properties of CDH from R. erythropolis DCL14. Spectra were recorded in 25 mM Hepes/NaOH, pH 7.0. A, absorption spectrum (from right to left, 2.5 mg/ml and of the 10 and 50 times diluted enzyme solution). B, fluorescence emission spectrum of 4 µM enzyme. Excitation was at 340 nm.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 4.   Spectral properties of CDH from R. erythropolis DCL14 in the presence of unfolding agents. A, fluorescence emission spectrum of 4 µM enzyme in 25 mM Hepes/NaOH, pH 7.0, after 1, 10, 30, 100, and 360 min of incubation with 0.5% SDS. The excitation wavelength was 280 nm. B, absorption spectrum of the urea-released cofactor of CDH. The free cofactor was obtained by gel filtration of 40 nmol of CDH over Bio-Gel P6DG in 10 mM Tris/HCl, pH 8.0, containing 1 mM dithiothreitol and 6 M urea. The inset shows the absorption spectrum of the apoprotein, eluting in the void volume of the column.

Identification of CDH-bound Cofactor-- The cofactor of CDH was firmly bound as indicated by gel filtration and dialysis experiments. Fluorescence spectral analysis revealed that the cofactor could be conveniently released from the CDH apoprotein by treatment with 0.5% SDS, 6 M urea, or 6 M guanidinium hydrochloride. Unfolding of CDH in 0.5% SDS was rather slow as indicated by the time-dependent disappearance of the fluorescence emission maximum at 440 nm and increase of protein fluorescence at 340 nm (Fig. 4A). In contrast, unfolding in 6 M urea (or 6 M guanidinium hydrochloride) was a rather rapid process, taking less than 10 min to complete (not shown).

The urea-released cofactor was separated from the apoprotein by gel filtration. Spectral analysis revealed that the apoprotein fraction exhibited an absorption maximum near 275 nm and no residual absorbance at 330 nm (Fig. 4B, inset). In line with this, no fluorescence emission was observed at 440 nm when the apoprotein sample was excited at either 280 or 340 nm. The absorption spectrum of the dissociated cofactor exhibited maxima at 260 and 340 nm, characteristic of NAD(P)H (Fig. 4B). Furthermore, the rather high A260/A340 ratio and relatively low fluorescence emission at 440 nm suggested that the CDH-bound cofactor is a mixture of oxidized and reduced pyridine nucleotide forms. The identity of the isolated cofactor was further established by anion-exchange chromatography, using conditions resulting in clear separation of NAD(H) and NAD(P)(H) (20). The CDH-derived cofactor preparation showed two peaks of nearly equal intensity at 260 nm, corresponding to the positions of NAD+ and NADH, respectively. In line with this, only the second elution peak of the CDH-derived cofactor preparation displayed absorption at 340 nm. From this it is concluded that CDH contains NAD(H) as the tightly bound cofactor. Moreover, assuming a molar absorption coefficient epsilon 340 = 6.22 mM-1 cm-1, the amount of NAD(H) per CDH subunit was estimated. Different enzyme preparations yielded values ranging from 0.55-0.98 mol NAD(H)/subunit, indicating that each CDH monomer contains one NAD(H) molecule as tightly bound cofactor.

Catalytic Properties-- Under the conditions of the standard assay, CDH was optimally active at pH 5.5 and showed 25% of the optimal activity at pH 4.6 and 7.0. The temperature optimum of CDH activity was near 50 °C. At pH 5.5, the specific activity gradually increased from 550 nmol min-1 mg-1 at 6 °C to 2825 nmol min-1 mg-1 at 50 °C. At temperatures above 35 °C, enzyme inactivation was observed during the time span of the activity assay, and at 60 °C activity was no longer detected. CDH used DCPIP as the electron acceptor. Over the pH range 6-9, no activity was observed with 9,10-anthraquinone, p-benzoquinone, cytochrome c, N,N-dimethyl-p-nitrosoaniline, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, flavin adenine dinucleotide, ferricyanide, ferrisulfate, flavin adenine mononucleotide, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride, menadione, methylene blue, NAD+, NADP+, nitroblue tetrazolium, oxygen, phenazine methosulfate, quinalizarin, tetramethyl-p-benzoquinone, triphenyltetrazolium and ubiquinone. The presence of phenazine methosulfate or NAD+ did not affect the DCPIP-dependent CDH activity at any of the tested pH values.

Substrate Specificity and Stereochemistry-- CDH showed a broad substrate specificity (Table III). The best substrates were substituted cyclohexanols such as carveol, 3-methylcyclohexanol, and 3,5,5-trimethyl-2-cyclohexen-1-ol. Primary alcohols such as ethanol and perillyl alcohol and short chain secondary alcohols like 2-propanol and 1-buten-3-ol were no substrates for CDH (Table III). Furthermore, no reverse reaction was detectable when CDH was assayed with (R)- or (S)-carvone or (4R)-dihydrocarvone in the presence of reduced DCPIP or NADH.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Substrate specificity of CDH from R. erythropolis DCL14

Because carveol exists in four stereoisomeric forms the kinetic constants of CDH with the pure stereoisomers were determined (Table IV). The highest Vmax/Km and lowest Km values were obtained for (4R, 6S)-carveol. Also a strong competitive product inhibition was observed and a Ki of 0.11 and 0.23 mM were determined for (R)- and (S)-carvone, respectively. Using a diastereomeric mixture of either (4R)- or (4S)-carveol as the substrate, the stereoselectivity of CDH was studied by chiral GC (Fig. 5). CDH converted only the (6S)-stereoisomers of carveol.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Kinetic constants of CDH from R. erythropolis DCL14 with the four stereoisomers of carveol


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   Stereoselectivity of the conversion of carveol by CDH. A, conversion of (4S)-carveol. B, conversion of (4R)-carveol. The reaction mixture contained 50 mM citrate, pH 6.0, 3 mM DCPIP, 2 mM carveol, and CDH (0.06 mg/ml and 0.02 mg/ml in panels A and B, respectively) (30 °C). , carvone; black-triangle, (6S)-stereoisomer of carveol; black-square, (6R)-stereoisomer of carveol.

N-terminal Sequence-- The N-terminal amino acid sequence determination of purified CDH gave a tandem sequence (a mixture of two identical peptide sequences, of which one lacked the first residue). The N-terminal sequence was determined to be Ala-Arg-Val-Glu-Gly-Gln-Val-Leu-Ile-Thr-Gly-Ala-Ala-ArgGly-Gln-Gly-Arg-Ser-His-Ala-Ile-Lys-(Lys/Leu)-(Ala/Leu)-GluGlu-Gly.

Nucleotide Sequence-- Recently, we cloned and sequenced the limA gene coding for limonene-1,2-epoxide hydrolase from R. erythropolis DCL14 (21). Sequencing the flanking regions of limA suggested that limA is the first open reading frame of an operon encoding genes involved in the limonene degradation pathway of this microorganism.2 The third open reading frame of this operon, limC, encodes a protein of 277 amino acids with a deduced molecular mass of 29.531 Da (Fig. 6). Residues 2-29 of the derived primary structure of limC corresponded to the N-terminal sequence of purified CDH, indicating that limC encodes CDH. A potential ribosomal-binding site (Shine-Dalgarno sequence), GGAGGGA, preceded the ATG translational initiation site by 2 base pairs (Fig. 6).


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 6.   Nucleotide sequence of the limC region of R. erythropolis DCL14 and the deduced amino acid sequence of CDH. Nucleotide sequence of the 834-base pair DNA fragment containing the limC gene. The open reading frame starts at base 37 and terminates at base 870. The deduced amino acid sequence is indicated below the DNA sequence. Underlined amino acid residues are identical to those determined by Edman degradation of the purified enzyme. A potential ribosome binding site (marked SD) upstream of the open reading frame is indicated.

Amino Acid Sequence Comparison-- The derived primary structure of CDH showed up to 33% sequence identity and 52% sequence homology with members of the SDR superfamily. The highest degree of sequence identity with enzymes of known structure was found for trihydroxynaphthalene reductase (Protein Data Bank code 1YBV) from Magnaporthe grisea (30%), human 17beta -hydroxysteroid dehydrogenase (1FMC) (29%), 3alpha ,20beta -hydroxysteroid dehydrogenase (2HSD) from Streptomyces hydrogenans (28%), and cis-biphenyl-2,3-dihydrodiol-2,3-dehydrogenase (1BDB) from Burkholderia cepacia (28%). Fig. 7 shows a sequence alignment of CDH and SDR enzymes of known three-dimensional structure. From the alignment it is obvious that CDH shares many structural features with the other members of the family. Conserved regions in the primary structure of CDH are present throughout the sequence indicating that the enzyme has an alpha /beta one-domain fold. Conserved features near the N terminus include the GXXXGXG fingerprint characteristic for the beta A-alpha B-beta B dinucleotide binding fold in dehydrogenases (42, 43) and Asp37, involved in determining the coenzyme specificity (43). Other conserved features include the Ser156-Tyr169-Lys173 catalytic triad with the YXXXK fingerprint, involved in substrate oxidation (44) and the NAG sequence (residues 102-104), involved in NADH binding (35, 43).


View larger version (69K):
[in this window]
[in a new window]
 
Fig. 7.   Multiple sequence alignment of CDH from R. erythropolis DCL14 and short chain dehydrogenases/reductases of known three-dimensional structure. The deduced amino acid sequence of CDH is aligned with the amino acid sequences of 1,3,8-trihydroxynaphthalene reductase (1YBV) from M. grisea (33), 7alpha -hydroxysteroid dehydrogenase (1FMC) from Escherichia coli (34), 3alpha ,20beta -hydroxysteroid dehydrogenase (2HSD) from S. hydrogenans (35), cis-biphenyl-2,3-dihydrodiol-2,3-dehydrogenase (1BDB) from B. cepacia (36), enoyl acyl carrier protein reductase (1ENO) from E. coli (37), human 17-beta -hydroxysteroid dehydrogenase (1FDS) (38), rat liver dihydropteridine reductase (1DHR) (39), mouse lung carbonyl reductase (1CYD) (40), and mouse sepiapterin reductase (1SER) (41). Secondary structure elements are underlined, and residues discussed in the text are depicted in bold type.

Structure Homology Modeling-- A three-dimensional model of the CDH structure was built, based on the crystal structure of 1YBV. A ribbon diagram of the modeled CDH structure is presented in Fig. 8; the predicted fold is highly similar to the alpha /beta one-domain fold of the SDR family (43). The modeled structure suggests that CDH contains at least 7 strands (beta A right-arrow beta G) and 7-9 helices (alpha B right-arrow alpha G). Two regions in the CDH model are not very well defined in relation to 1YBV and the other members of the SDR family with known three-dimensional structure. The first region includes a loop insertion between beta B and alpha C (residues 40-50) located near the entrance of the NADH binding site, which is new in relation to the other SDR members (Fig. 7). The second region concerns a loop comprising residues 204-236; in related SDR proteins this loop contains one or two helices and participates in substrate binding (34, 36). The modeled structure also suggests that the CDH subunits interact in a similar fashion as found in other tetrameric enzymes of the SDR family (33-36, 40). For the tetrameric contacts, probably the alpha E and alpha F interact along the Q-axis, the alpha G and beta G along the P-axis, and the weakest interaction occurs with the short C-terminal regions along the R-axis.


View larger version (66K):
[in this window]
[in a new window]
 
Fig. 8.   Ribbon diagram of the modeled three-dimensional structure of CDH from R. erythropolis DCL14. The three-dimensional structure of CDH was predicted by structure homology model building (26). The crystal structure of trihydroxynaphthalene reductase (1YBV) from M. grisea (33) served as the template. The schematic ribbon diagram was generated with MOLSCRIPT (45). The alpha -helices are drawn in red, the beta -sheets are in yellow, the flexible substrate binding region is in blue, the extra loop insertion (residue 40-50) is in green, and the NADH cofactor is in purple. The secondary structural elements are annotated together with the N and C termini.

Mode of Coenzyme Binding-- The NADH cofactor was modeled in an extended conformation, highly similar to related SDR members. The NADH molecule is buried in the protein and probably shielded from solvent by the extra loop, comprising residues 40-50 (Fig. 8). The nicotinamide ring was modeled in the syn conformation, consistent with the proposed stereochemistry of hydride transfer in the SDR family (35). Asp37 interacts in the model with the 2-OH ribose of NADH (Fig. 9), and the pyrophosphate moiety is located near the GXXXGXG sequence of the dinucleotide binding fold. The substrate binding cavity is enclosed on one side by the nicotinamide ring of NADH and the active site residue Tyr169 and on the other side by the C-terminal substrate binding loop.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 9.   Stereoview of the Calpha backbone of the CDH model. The N and C termini and each 15th residue is annotated in the stereopicture. The most important residues, Asp37, Ser156, Tyr169, and Lys173 (gray bonds) and the NADH cofactor (black bonds) are highlighted.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

This paper describes the purification and characterization of a DCPIP-dependent CDH, which is induced when R. erythropolis DCL14 is grown on monoterpenes. During the last decade it has become apparent that monoterpenes play an important role in chemical ecology where they act as attractants, repellents, sex pheromones, or alerting pheromones or are a part of defense secretion systems against predators (46). Remarkably, little is known about the metabolism of monoterpenes. Information regarding the enzymes involved in the monoterpene degradation pathways is especially scarce (6, 47, 48). Although CDH activity has been detected in crude extracts of spearmint (Mentha spicata) (49) and caraway (Carum carvi) (50), this is the first report of a CDH purified to homogeneity.

CDH from R. erythropolis DCL14 is a homotetramer, and each 30-kDa CDH subunit contains a tightly bound cofactor that is only released after treatment with unfolding agents. The cofactor was identified as NAD(H), indicating that CDH is a nicotinoprotein. Nicotinoproteins catalyze a large spread of reactions including transhydrogenation, dehydration, dismutation, epimerization, and oxidation of alcohols and aldehydes (51-57). Nicotinoprotein dehydrogenases can be divided in two groups. The first group includes dehydrogenases that catalyze oxidations dependent on exogenous NAD(P). However, due to an unusually high affinity, the (reduced) cofactor remains (partly) bound to the enzyme, even after lengthy purification procedures or repeated crystallization. Examples are glyceraldehyde-3-phosphate dehydrogenase (58) and mammalian acetaldehyde dehydrogenase (56). The second group includes nicotinoprotein dehydrogenases that are, in vitro, only active when assayed in the presence of an artificial electron acceptor like N,N-dimethyl-4-nitrosoaniline or DCPIP (57, 59, 60). In vivo, these enzymes probably regenerate the cofactor by delivering the reduction equivalents directly to a component of an electron transport chain (61). Examples are methanol dehydrogenase from Amycolatopsis methanolica (57), short chain primary alcohol dehydrogenase from A. methanolica (60), and medium chain primary alcohol dehydrogenase from Methanosarcina barkeri (59). Being exclusively active with DCPIP, it is evident that CDH belongs to this second group of nicotinoprotein dehydrogenases. However, the physiological electron acceptor of the enzyme remains to be elucidated.

Gene cloning confirmed that CDH is involved in the biodegradation of limonene and sequence analysis classified CDH as a member of the SDR superfamily. These enzymes are built up by subunits of about 30 kDa, do not contain metal cofactors, have a single alpha /beta domain with a beta A-alpha B-beta B dinucleotide binding fold near the N termini, and contain a highly conserved Ser-Tyr-Lys triad at their active site (44, 62). In CDH, the catalytic machinery includes Ser156, Tyr169, and Lys173. Ser156 and Tyr169 are likely involved in substrate activation, whereas Lys173 presumably is involved in the orientation of the nicotinamide ring of the cofactor (33). Moreover, the presence of an aspartic residue, 18 residues downstream of the GXXXGXG fingerprint, confirmed the biochemical identification of the coenzyme specificity of CDH (40).

Structure prediction suggests that CDH contains a 10-amino acid-long loop (residues 40-50) located near the entrance of the NADH binding cleft. This loop, which is absent in other SDR members of known structure, might be involved in shielding the NADH cofactor from the bulk solvent. Another intriguing feature concerns the functional role of the flexible loop comprising residues 204-236. As proposed for 7alpha -hydroxysteroid dehydrogenase (34) and confirmed by the structure of trihydroxynaphthalene reductase complexed with tricyclazole (33), this part of the sequence is likely involved in determining the substrate specificity. Moreover, from the conservation of several critical residues, we propose that in CDH a hinge bending motion of the substrate binding loop occurs. Thr204 (N-terminal hinge) and Asn236 (C-terminal hinge) might act as the hinges, whereas Pro199 and Pro239 probably stabilize the region close to the hinges (34).

CDH from R. erythropolis has a unique substrate specificity in comparison with previously reported (secondary) alcohol dehydrogenases (63-65). The enzyme has a preference for substituted cyclohexanols and does not catalyze the oxidation of primary or short chain aliphatic secondary alcohols. CDH shows an absolute stereoselectivity with carveol, converting only the (6S)-stereoisomers when incubated with a diastereomeric mixture. This stereoselectivity is explained by the kinetic constants of CDH, showing a much higher catalytic efficiency for the (6S)-stereoisomers than for the (6R)-stereoisomers and the simultaneous strong competitive product inhibition. Absolute stereoselectiveness is a unique property among secondary alcohol dehydrogenases (66-68), potentially making the enzyme of interest for the biocatalytic production of (natural) enantiopure compounds.

In conclusion, DCPIP-dependent CDH from R. erythropolis DCL14 is a novel nicotinoprotein with a SDR alpha /beta one-domain fold. The enzyme catalyzes the stereoselective conversion of monoterpenes, which further extends the functional diversity of the SDR superfamily.

    ACKNOWLEDGEMENTS

We thank Martin de Wit for technical assistance, Harro Bouwmeester (AB-DLO, Wageningen, The Netherlands) for providing us with standards of the different stereoisomers of carveol, Elbert van der Klift (Department of Organic Chemistry, Wageningen University) for help with preparative GC, and Henk Swarts (Department of Organic Chemistry, Wageningen University) for the synthesis of (4S)-carveol and help with the GC-MS analysis.

    FOOTNOTES

* This work was supported by Grants BIO4-CT95-0049 and BIO4-CT96-5132 from the European Community.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AJ006869.

§ To whom correspondence should be addressed: Div. of Industrial Microbiology, Department of Food Technology and Nutritional Sciences, Wageningen University, P.O. Box 8129, 6700 EV Wageningen, The Netherlands. Tel.: 31-317-484412; Fax: 31-317-484978; E-mail: mariet.vanderwerf@imb.ftns.wau.nl.

2 C. J. B. van der Vlugt-Bergmans, F. Barbirato, J. A. M. de Bont, and M. J. van der Werf, unpublished results.

    ABBREVIATIONS

The abbreviations used are: DCPIP, dichlorophenolindophenol; CDH, carveol dehydrogenase; GC, gas chromatography; MS, mass spectrometry; SDR, short chain dehydrogenase/reductase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Harborne, J. B. (1991) in Ecological Chemistry and Biochemistry of Plant Terpenoids (Harborne, J. B. , and Tomas-Barberan, F. A., eds) , pp. 399-426, Clarendon Press, Oxford
2. Devon, T. K., and Scott, A. I. (1972) Handbook of Naturally Occurring Compounds: Terpenes , Vol. II , pp. 3-54, Academic Press, New York
3. Guenther, A., Hewitt, C. N., Erickson, D., Fall, R., Geron, C., Graedel, T., Harley, P., Klinger, L., Ledau, M., McKay, W. A., Pierce, T., Scholes, B., Steinbrecher, R., Tallamraju, R., Taylor, J., and Zimmerman, P. (1995) J. Geophys. Res. 100, 8873-8892[CrossRef]
4. Burdock, G. A. (1995) Fenaroli's Handbook of Flavour Ingredients , 3rd Ed. , p. 107, CRC Press, Boca Raton, FL
5. Nonino, E. A. (1997) Perf. Flav. 22, 53-58
6. Trudgill, P. W. (1986) in The Bacteria: A Treatise on Structure and Function (Sokatch, J. R., ed), Vol. X , pp. 483-525, Academic Press, Orlando, FL
7. Dhavalikar, R. S., Rangachari, P. N., and Bhattacharyya, P. K. (1966) Indian J. Biochem. 3, 158-164[Medline] [Order article via Infotrieve]
8. Teunissen, M. J., and de Bont, J. A. M. (1995) in Bioflavour 95 (Étiévant, P. , and Schreier, P., eds) , pp. 329-337, INRA, Paris
9. Gabrielyan, K. A., Menyailova, I. I., and Nakhapetyan, L. A. (1992) Appl. Biochem. Microbiol. 28, 241-245
10. van Dyk, M. S., van Rensburg, E., and Moleleki, N. (1998) Biotechnol. Lett. 20, 431-436[CrossRef]
11. Ballal, N. R., Bhattacharyya, P. K., and Rangachari, P. N. (1967) Biochem. Biophys. Res. Commun. 29, 275-280[CrossRef][Medline] [Order article via Infotrieve]
12. Ballal, N. R., Bhattacharyya, P. K., and Rangachari, P. N. (1968) Indian J. Biochem. 5, 1-6[Medline] [Order article via Infotrieve]
13. Cadwallader, K. R., Braddock, R. J., and Parish, M. E. (1992) J. Food Sci. 57, 241-244[CrossRef]
14. van der Werf, M. J., Swarts, H. J., and de Bont, J. A. M. (1999) Appl. Environ. Microbiol. 65, 2092-2102[Abstract/Free Full Text]
15. van der Werf, M. J., Overkamp, K. M., and de Bont, J. A. M. (1998) J. Bacteriol. 180, 5052-5057[Abstract/Free Full Text]
16. Hartmans, S., Smits, J. P., van der Werf, M. J., Volkering, F., and de Bont, J. A. M. (1989) Appl. Environ. Microbiol. 55, 2850-2855[Abstract/Free Full Text]
17. Armstrong, J. McD. (1964) Biochim. Biophys. Acta 86, 194-197[Medline] [Order article via Infotrieve]
18. van der Werf, M. J., van den Tweel, W. J. J., and Hartmans, S. (1993) Appl. Environ. Microbiol. 59, 2823-2829[Abstract/Free Full Text]
19. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
20. Arfman, N., Hektor, H. J., Bystrykh, L. V., Govorukhin, N. I., Dijkhuizen, L., and Frank, J. (1997) Eur. J. Biochem. 244, 426-433[Medline] [Order article via Infotrieve]
21. Barbirato, F., Verdoes, J. C., de Bont, J. A. M., and van der Werf, M. J. (1998) FEBS Lett. 438, 293-296[CrossRef][Medline] [Order article via Infotrieve]
22. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
23. Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389-3402[Abstract/Free Full Text]
24. Lu, G. (1996) Protein Data Bank Quarterly Newsletter 78, 10-11
25. Schuler, G. D., Altschul, S. F., and Lipman, D. J. (1991) Proteins Struct. Funct. Genet. 9, 180-190[CrossRef][Medline] [Order article via Infotrieve]
26. Sali, A., and Blundell, T. L. (1993) J. Mol. Biol. 234, 779-815[CrossRef][Medline] [Order article via Infotrieve]
27. Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swiminathan, S., and Karplus, M. (1983) J. Comp. Chem. 4, 187-217
28. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291[CrossRef]
29. Lüthy, R., Bowie, J. U., and Eisenberg, D. (1992) Nature 356, 83-85[CrossRef][Medline] [Order article via Infotrieve]
30. Sippl, M. J. (1993) Proteins 17, 355-362[CrossRef][Medline] [Order article via Infotrieve]
31. Brünger, A. T. (1992) X-PLOR, version 3.1 , Yale University Press, New Haven, CT
32. Jones, T. A., Zou, J.-Y., Cowan, S., and Kjeldgaard, M. (1991) Acta Crystallogr. Sec. A 47, 110-119
33. Andersson, A., Jordan, D., Schneider, G., and Lindqvist, Y. (1996) Structure 4, 1161-1170[Medline] [Order article via Infotrieve]
34. Tanaka, N., Nonaka, T., Tanabe, T., Yoshimoto, T., Tsuru, D., and Mitsui, Y. (1996) Biochemistry 35, 7715-7730[CrossRef][Medline] [Order article via Infotrieve]
35. Ghosh, D., Wawrzak, Z., Weeks, C. M., Duax, W. L., and Erman, M. (1994) Structure 2, 629-640[Medline] [Order article via Infotrieve]
36. Hülsmeyer, M., Hecht, H.-J., Niefind, K., Hofer, B., Eltis, L. D., Timmis, K. N., and Schomburg, D. (1998) Protein Sci. 7, 1286-1293[Medline] [Order article via Infotrieve]
37. Rafferty, J. B., Simon, J. W., Baldock, C., Artymiuk, P. J., Baker, P. J., Stuitje, A. R., Slabas, A. R., and Rice, D. W. (1995) Structure 3, 927-938[Medline] [Order article via Infotrieve]
38. Breton, R., Housset, D., Mazza, C., and Fontecilla-Camps, J. C. (1996) Structure 4, 905-915[Medline] [Order article via Infotrieve]
39. Varughese, K. I., Skinner, M. M., Whiteley, J. M., Matthews, B. W., and Xuong, N. H. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6080-6084[Abstract/Free Full Text]
40. Tanaka, N., Nonaka, T., Nakanishi, M., Deyashiki, Y., Hara, A., and Mitsui, Y. (1996) Structure 4, 33-45[Medline] [Order article via Infotrieve]
41. Auerbach, G., Herrmann, A., Gütlich, M., Fischer, M., Jacob, U., Bacher, A., and Huber, R. (1997) EMBO J. 16, 7219-7230[CrossRef][Medline] [Order article via Infotrieve]
42. Rossmann, M. G., Moras, D., and Olsen, K. W. (1974) Nature 250, 194-199[CrossRef][Medline] [Order article via Infotrieve]
43. Wierenga, R. K., Terpstra, P., and Hol, W. G. J. (1986) J. Mol. Biol. 187, 101-107[CrossRef][Medline] [Order article via Infotrieve]
44. Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Durarte, R., Feffery, J., and Ghosh, D. (1995) Biochemistry 34, 6003-6013[CrossRef][Medline] [Order article via Infotrieve]
45. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950[CrossRef]
46. Banthorpe, D. V. (1995) in Natural Products: Their Chemistry and Biological Significance (Mann, J., ed) , pp. 289-359, Longman Scientific & Technical, Essex, UK
47. Trudgill, P. W. (1994) in Biochemistry of Microbial Degradation (Ratledge, C., ed) , pp. 33-61, Kluwer Academic Publishers, Dordrecht, The Netherlands
48. van der Werf, M. J., de Bont, J. A. M., and Leak, D. J. (1997) Adv. Biochem. Eng. Biotechnol. 55, 147-177
49. Gershenzon, J., Maffei, M., and Croteau, R. (1988) Plant Physiol. 89, 1351-1357[CrossRef]
50. Bouwmeester, H. J., Gershenzon, J., Konings, M. C. J. M., and Croteau, R. (1998) Plant Physiol. 117, 901-912[Abstract/Free Full Text]
51. Allen, S. H. G. (1966) J. Biol. Chem. 241, 5266-5275[Abstract/Free Full Text]
52. Frey, P. A. (1987) in Pyridine Nucleotide Coenzymes (Dolphin, D., Avramovic, O., and Poulson, R., eds) part B, pp. 461-511, John Wiley & Sons, New York
53. Kato, N., Yamagami, T., Shimao, M., and Sakazawa, C. (1986) Eur. J. Biochem. 156, 59-64[Medline] [Order article via Infotrieve]
54. Bauer, A. J., Rayment, I., Frey, P. A., and Holden, H. M. (1992) Proteins 12, 372-381[CrossRef][Medline] [Order article via Infotrieve]
55. Kirkman, H. N., and Faetani, G. F. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 4343-4347[Abstract/Free Full Text]
56. Ramsey, A. J., Hill, J. P., and Dickinson, F. M. (1989) Comp. Biochem. Physiol. 93B, 77-83
57. Bystrykh, L. V., Vonck, J., van Bruggen, E. F. J., van Beeumen, J., Samyn, B., Govorukhina, N. I., Arfman, N., Duine, J. A., and Dijkhuizen, L. (1993) J. Bacteriol. 175, 1814-1822[Abstract/Free Full Text]
58. Klepp, J., Oberfrank, M., Retey, J., Tritsch, D., Biellmann, J.-F., and Hull, W. E. (1989) J. Am. Chem. Soc. 111, 4440-4447[CrossRef]
59. Daussmann, T., Aivasidis, A., and Wandrey, C. (1997) Eur. J. Biochem. 248, 889-896[Medline] [Order article via Infotrieve]
60. van Ophem, P. W., van Beeumen, J., and Duine, J. A. (1993) Eur. J. Biochem. 212, 819-826[Medline] [Order article via Infotrieve]
61. Duine, J. A. (1995) Biosens. Bioelectr. 10, 17-23
62. Reid, M. F., and Fewson, C. A. (1994) Crit. Rev. Microbiol. 20, 13-56[Medline] [Order article via Infotrieve]
63. Ludwig, B., Akundi, A., and Kendall, K. (1995) Appl. Environ. Microbiol. 61, 3729-3733[Abstract]
64. Ashraf, W., and Murrell, J. C. (1990) Arch. Microbiol. 153, 163-168[CrossRef]
65. Stirling, L. A., and Perry, J. J. (1980) Curr. Microbiol. 4, 37-40
66. Secundo, F., and Philips, R. S. (1996) Enzyme Microb. Technol. 19, 487-492[CrossRef]
67. Stone, C. L., Li, T.-K., and Bosron, W. F. (1989) J. Biol. Chem. 264, 11112-11116[Abstract/Free Full Text]
68. Hummel, W., and Kula, M.-R. (1989) Eur. J. Biochem. 184, 1-13[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Appl. Environ. Microbiol.Home page
D. Kim, J.-C. Chae, G. J. Zylstra, Y.-S. Kim, S.-K. Kim, M. H. Nam, Y. M. Kim, and E. Kim
Identification of a Novel Dioxygenase Involved in Metabolism of o-Xylene, Toluene, and Ethylbenzene by Rhodococcus sp. Strain DK17
Appl. Envir. Microbiol., December 1, 2004; 70(12): 7086 - 7092.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
R. Warren, W. W. L. Hsiao, H. Kudo, M. Myhre, M. Dosanjh, A. Petrescu, H. Kobayashi, S. Shimizu, K. Miyauchi, E. Masai, et al.
Functional Characterization of a Catabolic Plasmid from Polychlorinated- Biphenyl-Degrading Rhodococcus sp. Strain RHA1
J. Bacteriol., November 15, 2004; 186(22): 7783 - 7795.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
W. A. Duetz, A. H. M. Fjällman, S. Ren, C. Jourdat, and B. Witholt
Biotransformation of D-Limonene to (+) trans-Carveol by Toluene-Grown Rhodococcus opacus PWD4 Cells
Appl. Envir. Microbiol., June 1, 2001; 67(6): 2829 - 2832.
[Abstract] [Full Text]


Home page
Appl. Environ. Microbiol.Home page
C. J. B van der Vlugt-Bergmans and M. J. van der Werf
Genetic and Biochemical Characterization of a Novel Monoterpene {varepsilon}-Lactone Hydrolase from Rhodococcus erythropolis DCL14
Appl. Envir. Microbiol., February 1, 2001; 67(2): 733 - 741.
[Abstract] [Full Text]


Home page
MicrobiologyHome page
M. J. van der Werf and A. M. Boot
Metabolism of carveol and dihydrocarveol in Rhodococcus erythropolis DCL14
Microbiology, May 1, 2000; 146(5): 1129 - 1141.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G.-F. Jang, J. K. McBee, A. M. Alekseev, F. Haeseleer, and K. Palczewski
Stereoisomeric Specificity of the Retinoid Cycle in the Vertebrate Retina
J. Biol. Chem., September 1, 2000; 275(36): 28128 - 28138.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Werf, M. J.
Right arrow Articles by van Berkel, W. J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Werf, M. J.
Right arrow Articles by van Berkel, W. J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement